Regarding patients with PC, knowledge of the presence of BRCA1/2 mutations in cancer tissue (somatic mutations) or in peripheral blood (germline mutations) provides useful information of prognostic and predictive value. Here, BRCA1 is linked to pachyonychia congenita.